Literature DB >> 9890939

CREB-binding protein is a nuclear integrator of nuclear factor-kappaB and p53 signaling.

R Wadgaonkar1, K M Phelps, Z Haque, A J Williams, E S Silverman, T Collins.   

Abstract

Transcriptional coactivators may function as nuclear integrators by coordinating diverse signaling events. Here we show that the p65 (RelA) component of nuclear factor-kappaB (NF-kappaB) and p53 mutually repress each other's ability to activate transcription. Additionally, tumor necrosis factor-activated NF-kappaB is inhibited by UV light-induced p53. Both p65 and p53 depend upon the coactivator CREB-binding protein (CBP) for maximal activity. Increased levels of the coactivator relieve p53-mediated repression of NF-kappaB activity and p65-mediated repression of p53-dependent gene expression. Nuclear competition for limiting amounts of CBP provides a novel mechanism for altering the balance between the expression of NF-kappaB-dependent proliferation or survival genes and p53-dependent genes involved in cell cycle arrest and apoptosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9890939     DOI: 10.1074/jbc.274.4.1879

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  54 in total

Review 1.  Dial 9-1-1 for p53: mechanisms of p53 activation by cellular stress.

Authors:  M Ljungman
Journal:  Neoplasia       Date:  2000 May-Jun       Impact factor: 5.715

Review 2.  New insights into the role of nuclear factor-kappaB in cell growth regulation.

Authors:  F Chen; V Castranova; X Shi
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

3.  Nuclear factor-kappaB regulates inflammatory cell apoptosis and phagocytosis in rat carrageenin-sponge implant model.

Authors:  Maria Chiara Maiuri; Gianfranco Tajana; Teresa Iuvone; Daniela De Stefano; Guido Mele; Maria Teresa Ribecco; Maria Pia Cinelli; Maria Fiammetta Romano; Maria Caterina Turco; Rosa Carnuccio
Journal:  Am J Pathol       Date:  2004-07       Impact factor: 4.307

Review 4.  p53-mediated neuronal cell death in ischemic brain injury.

Authors:  Li-Zhi Hong; Xiao-Yuan Zhao; Hui-Ling Zhang
Journal:  Neurosci Bull       Date:  2010-06       Impact factor: 5.203

Review 5.  Therapeutic targets for hypoxia-elicited pathways.

Authors:  C T Taylor; S P Colgan
Journal:  Pharm Res       Date:  1999-10       Impact factor: 4.200

6.  Transcription factor NF-kappaB differentially regulates death receptor 5 expression involving histone deacetylase 1.

Authors:  Shashirekha Shetty; Bonnie A Graham; Jennifer G Brown; Xiaojie Hu; Nicolette Vegh-Yarema; Gary Harding; James T Paul; Spencer B Gibson
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

7.  MDM2-dependent inhibition of p53 is required for Epstein-Barr virus B-cell growth transformation and infected-cell survival.

Authors:  Eleonora Forte; Micah A Luftig
Journal:  J Virol       Date:  2009-01-14       Impact factor: 5.103

8.  Sustained NF-kappaB activation produces a short-term cell proliferation block in conjunction with repressing effectors of cell cycle progression controlled by E2F or FoxM1.

Authors:  Marianna Penzo; Paul E Massa; Eleonora Olivotto; Francesca Bianchi; Rosa Maria Borzi; Adedayo Hanidu; Xiang Li; Jun Li; Kenneth B Marcu
Journal:  J Cell Physiol       Date:  2009-01       Impact factor: 6.384

Review 9.  NF-kappaB, a pivotal transcription factor in silica-induced diseases.

Authors:  Fei Chen; Xianglin Shi
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

10.  Tumor necrosis factor alpha (TNF) suppresses cAMP response element (CRE) activity and nuclear CRE binding protein in MA-10 mouse Leydig tumor cells.

Authors:  Koji Y Arai; Katherine F Roby; Paul F Terranova
Journal:  Endocrine       Date:  2005-06       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.